Tag Archive for: healthtech PR

Key Takeaways

  • Industry expertise means your stage as well as your sector. Look for an agency that understands venture funding cycles, board dynamics, and the scrutiny that comes with growth.
  • Judgment and measurement separate strategy from activity. A strong agency challenges weak story ideas and ties results to investor interest, customer acquisition, and talent recruitment.
  • Senior access is a staffing question. Know who leads your strategy and who makes the decisions when the stakes rise.

A strong tech PR agency understands what sets your company apart, identifies the audiences to reach, and turns your position in the market into a credible story.

Effective tech PR today connects communications to business goals, such as raising capital, winning customers, and attracting talent. For a primer on the discipline itself, see what tech PR is.

Use these seven criteria to evaluate a partner.

What to Look for in a Tech PR Agency

1. Deep Tech Industry Expertise

Technology covers very different markets. A fintech company, healthtech platform, cybersecurity provider, AI business, enterprise SaaS company, cleantech company, and consumer technology brand each face distinct audiences, regulations, buying cycles, and competitive pressures.

Look for an agency that understands venture funding cycles and board dynamics, complex product categories, and the scrutiny that comes with growth, pivots, and scale. An agency that understands your stage and sector will build messaging that resonates with investors, analysts, customers, and journalists alike.

Sector experience counts most in regulated fields like fintech and healthtech, so ask how the team learns your market, not only who they’ve worked with. Three questions help:

  • • What business challenge did the PR program address?
  • • How did the team shape the company’s narrative?
  • • What changed as a result of the work?

For a longer list, see Worst Questions to Ask Your Agency and What to Ask Instead.

2. Strategic Judgment Over Hype

Technology companies face constant pressure to announce something new. AI launches, product updates, funding news, partnerships, and executive appointments all compete for attention. That doesn’t make every announcement newsworthy.

Ask how the team handles a weak story idea. A good agency will challenge an inflated claim, question an angle that lacks evidence, or recommend waiting until the company has something meaningful to say.

Look for a team that builds narrative architecture: defensible positioning, grounded in what the company can prove, and reinforces it consistently across funding announcements, product launches, executive bylines and interviews, and crisis moments.

During your evaluation, ask: What does this mean for the market? Why would a customer, investor, or partner care? What can the company credibly say that competitors can’t?

3. Integration with SEO and AI Visibility

Customers, investors, and partners increasingly use search engines and AI systems to research companies, products, executives, and market categories. Earned media shapes what they find and how they understand your business.

An experienced agency understands how earned media, search, and AI discovery interact. A good team connects communications priorities to the questions your audiences ask and the sources that influence their understanding.

Explore whether the agency can identify:

  • The topics your company needs to be associated with
  • The questions potential customers and stakeholders ask before making decisions
  • The authoritative sources that influence search results and AI-generated answers
  • Whether earned media reinforces your core messages and market position
  • How competitors appear in the same search and AI environments

Press coverage trains how AI systems represent your brand. An agency that ignores this shift lets incomplete or outdated information define your story.

4. Measurement Tied To Business Goals

PR success should connect to business objectives, not vanity metrics. Look for agencies that measure investor inbound interest, talent acquisition quality, category authority and share of voice, AI-generated search representation, and reputation stability during inflection points.

The right priorities depend on your business, whether you’re preparing for a funding round, pursuing enterprise customers, entering a new market, or competing for specialized talent. Agree on priorities and measurement before the engagement begins. Strategic PR should reduce sales friction, strengthen valuation positioning, and improve stakeholder confidence.

For the full framework, see What Is PR ROI? 

5. Senior-Level Attention and Cultural Fit

Tech companies move quickly. Messaging shifts. Market conditions change.

Who will be in the room when strategic decisions need to be made? Clarify who will develop the strategy, advise executives, handle sensitive communications, and make judgment calls when an opportunity or crisis emerges. Meet the people who will lead the work, not just the team presenting the pitch. When senior people pitch and junior people deliver, the support a company expected and the support it receives drift apart.

For a growing technology business, experienced counsel helps leadership assess a risky announcement, respond to an investor’s concern, or decide when a story needs more evidence before it goes public. Those calls take business judgment.

Make the staffing model explicit. Confirm how often senior strategists will participate, who owns the relationship, and who steps in when an important decision can’t wait. The right partner feels like an extension of your executive team.

6. Crisis Readiness and Reputation Management

A product issue, security breach, regulatory development, executive departure, layoff, or customer complaint can quickly change how people view a technology company.

Ask a prospective agency to identify the three crises most likely to affect your business. Then ask who speaks first, which audience receives the first communication, and what facts the company needs before responding.

A prepared agency can explain how it would coordinate executives, legal counsel, employees, customers, investors, and other stakeholders as the situation develops. It can also distinguish what the company knows from what it still needs to verify.

Explore the agency’s approach to crisis communications before a problem arises.

7. Global Capabilities When Needed

If your company operates internationally or plans to scale globally, your PR partner needs to understand the audiences in those markets. Look for support with cross-border media outreach, international investor visibility, regional regulatory communication, and multinational product launches.

Assess how the agency adapts messaging for different regions, selects relevant media, and accounts for local business culture and regulatory considerations. Find out whether the team works directly with local specialists or relies on a network of external contacts.

Your agency needs to preserve the company’s core positioning while adapting the story to local expectations. Match its geographic capabilities to your actual expansion plans.

How to Narrow Your Shortlist

Once you know what to look for in a technology PR partner, the next step is deciding what type of agency fits your needs. The B2B tech PR agency selection guide explores the boutique versus large-firm decision. From there, the guide to choosing a boutique tech PR agency helps you evaluate which boutique firm fits your company.

Call Avaans Media 

Which of these seven criteria carries the most weight for your company right now? An assessment from Avaans Media shows where your narrative is working, where it needs attention, and what a senior strategist would tackle first.

Health and wellness brands become very good at building consumer trust. They have to. When a product affects how someone sleeps or manages a chronic condition, every purchase decision runs through a trust filter. But as a wellness company grows, it attracts a different kind of attention. Retail buyers, investors, and acquirers want to understand the company, not just the product. They’re looking in places most wellness brands never think to build visibility.

Why Investor PR for Health and Wellness Brands Matters Earlier Than Founders Think

Years of steady coverage don’t automatically create authority with capital audiences.  Most health and wellness PR is built to collect mentions, not build credibility with investors. But an investor researching your company wants to understand what the business stands for, what category position it holds, and why it commands a premium. They’re reading trade publications like Rock Health, Fierce Healthcare, MedCity News, and Forbes Health, and if your wellness brand isn’t showing up there, you’ve missed the chance to educate a financially sophisticated audience on why your company deserves their attention.

That gap in capital-market visibility develops because most wellness brands build a consumer PR program and stop. What they actually need is two programs, a consumer program and an investor-facing program, built from the same narrative foundation so the message stays consistent regardless of who’s reading it.

Case Study: A first-time wellness brand entered retail with no paid media budget and an entirely new product category to explain. Avaans Media combined executive authority, national earned media, and industry recognition to build credibility with both consumers and industry stakeholders, helping triple DTC sales and secure retail placement. See the full case study

Why Most Wellness Brands Never Build Capital-Market Visibility

Most wellness brands don’t think of capital-market visibility as something they need. When consumer metrics look healthy, investor-facing visibility slides off the agenda. It’s easy to lose track of an audience you were never explicitly building for.

But wellness attracts serious capital. CPG conglomerates, pharma, digital health VCs, and health-focused PE firms are all active in the category (Rock Health tracks this extensively). The brands that close rounds efficiently and command strong multiples built investor-facing visibility before they needed it.

If that’s where you are, an assessment will tell you what your current program is building for capital audiences and what it isn’t.</em>

For healthtech specifically, the window is even shorter, because it is a regulated industry.

Narrative Leakage Creates Problems for Investors, Not Just Consumers

Narrative Leakage develops when coverage has no common thread. A wellness founder gets a product feature in Well+Good, a podcast covers the origin story, a trade pub runs a quote about supply chain transparency, and a business journal profiles the company’s growth. 

Every placement is legitimate, but an investor reading those pieces in sequence can’t arrive at a clear picture of what the company stands for or why it deserves capital attention. The narrative disperses instead of building, and because AI tools synthesize patterns across a coverage record rather than counting mentions, a fragmented record doesn’t just fail to impress. It actively works against you, because the picture an investor or acquirer forms from that record is the one they bring into every conversation that follows.

The stakes are higher in regulated categories, where that fragmented picture can shape both a valuation and a regulator’s read on the company.

Brand Authority Influences Valuation in Health and Wellness

Consumer wellness is a low-trust category, which means brand authority carries more financial weight here than in most consumer categories. When two wellness brands with similar financials go to market, the one with established authority in credible publications commands a higher multiple. That premium is built through Earned Media, not paid channels, and it’s calculable: it’s the difference between a buyer paying $50M for a company with $8M in EBITDA and the $24M a straight earnings multiple would suggest.

Most wellness brands also leave a compliance dimension completely untouched as a narrative asset. Third-party certifications, clinical advisory relationships, transparent sourcing, and manufacturing standards are evidence that journalists, retailers, and investors can evaluate independently. In a category where product claims face legal constraints, operational rigor is available as a credibility signal. Most wellness brands aren’t using it.

How the Fingerprint Strategy Builds Consumer and Investor Communications Together

This is the problem Avaans Media’s Fingerprint PR Strategy was built to solve. The diagnostic identifies what a company can credibly own in its market. From that foundation, builds two coordinated programs: one for consumer audiences, one for capital audiences, both telling the same story in different registers.

If you want to understand what your current PR program is building for capital audiences, and what it isn’t, an assessment is where that conversation starts. That’s regulatory risk layered on top of valuation risk.

Case Study: A consumer wellness brand in a regulated category began building investor-facing authority years before its IPO window opened. By the time institutional investors began their diligence, the company had already established a multi-year editorial record across consumer, trade, and business media. The IPO was oversubscribed and the stock increased 300% at launch. See the full case study.

The Window Is Earlier Than You Think

Most founders assume they can address capital-market visibility when they need it. The founders who get this right know better. The coverage record investors find when they search your company was built long before they looked. By the time a raise is active, there’s no fast way to rebuild what wasn’t built. Which is why they start years earlier, not months.

 

The Invisible Asset, written by Avaans Media founder Tara Coomans, is the PR ROI framework that builds brand equity, drives valuation, attracts capital, and wins high-stakes moments. It’s built for CMOs defending budgets, CEOs preparing for a capital event, and operators in regulated categories. Get the book →

When companies begin raising capital, PR takes on a second responsibility.

 Most consumer brands build their PR playbook around a single goal: earning the trust and attention of customers. Coverage drives awareness trust, marketing efficiency and revenue. For many companies, that is enough for years. But once capital is involved, PR starts influencing valuation.

When capital enters the picture, the company itself becomes the product being evaluated. Investors, analysts, lenders, and future acquirers aren’t evaluating whether customers will buy. They’re evaluating whether the business itself is worth backing.

That shift changes the role of communications. Before a company raises capital, PR is largely measured by its ability to influence demand. As the audience expands beyond customers, communications begin influencing perceived company value. Reputation, authority, leadership visibility, and credibility all become part of the valuation story.

This is where PR for Product and PR for Capital begin to diverge: one helps people decide whether to buy, and the other helps investors decide what the company may be worth.

The difference between PR for product and PR for capital becomes increasingly important as new stakeholders enter the picture. If you’re at that inflection point now, an assessment tells you whether your current PR infrastructure is built for both audiences or just one.

Two Audiences, Two Different Jobs

Understanding the distinction between PR for product and PR for capital helps companies build credibility with both customers and investors:

Product PR is built to move customers. Its proof points are customer-facing: what the product does, how it’s different, what it feels like to use. The storytelling can be emotional and aspirational. Success is measured through awareness, sentiment, and sales impact.

Capital PR is designed to influence investors, analysts, and financial media. These audiences are not asking whether they like the product. They are evaluating whether the market opportunity is real, whether the business can scale, and whether leadership can execute against the growth story.

The two audiences drive different outcomes. Customer perception affects revenue. Investor perception affects access to capital, financing terms, strategic opportunities, and ultimately, valuation.

The proof points shift accordingly. Investors want evidence that future valuation is supported by underlying business fundamentals, such as market size, defensibility, revenue growth, retention, and a credible path to scale as well as reputation and category dominance.

The timeline shifts as well. Investor confidence develops over quarters, not campaign cycles. 

Companies that consistently engage financial audiences through executive positioning, financial media, and thought leadership arrive at capital events with greater credibility than those that only begin communicating when they need funding. This is why investor-facing visibility during the hold period becomes a strategic advantage rather than a last-minute communications exercise. The same logic applies in fintech, where IPO and M&A processes bring their own investor-facing requirements.

For regulated consumer brands, the stakes of getting this wrong are higher than most. Here’s why regulated brands specifically need both tracks running simultaneously.

Where the Two Tracks Diverge 

Once a company is running both, the differences become practical:

The language changes. Consumer storytelling can afford to be loose and evocative. Investor communications must be precise and, in regulated industries, compliant. A founder interview that works perfectly in a lifestyle publication may require significant recalibration before appearing in financial media.

The proof points change. Customers want evidence that a product works. Investors want evidence that the business has depth AND scalability. In healthtech specifically, that evidence has to be measured and shown before a raise, not assembled after one.

The spokespeople may change. A founder who excels at telling the brand story is not always the best person to discuss capital allocation, market structure, or exit strategy. Developing the right voice for each audience often produces stronger outcomes than expecting one executive to fill every role.

The consequences of mistakes are different. A product PR misstep damages brand perception. But a capital communications misstep can affect financing terms, complicate a transaction, or create regulatory exposure.

The Transition Happens Earlier Than Most Founders Expect

Many companies wait until a raise is underway before thinking seriously about investor communications, but by then they are already behind.

By the time a company is in serious Series B conversations or beginning any kind of pre-IPO process,investors have often already formed impressions based on what they can find publicly. 

Coverage, executive visibility, thought leadership, and third-party validation collectively become part of the valuation narrative long before a term sheet appears.

The most common mistake is assuming existing PR infrastructure can absorb capital communications without structural changes. The result is often investor materials that read like marketing collateral,or financial communications that lose the distinctive story behind the business.

When the two streams drift apart without anyone managing the connection, important parts of the company’s narrative begin appearing in places that they were never intended to live. That’s narrative leakage, and it’s one of the most common challenges brands face when capital conversations become serious. Regulated brands face a sharper version of this problem, where the two narratives have to hold together under more scrutiny.

What Getting It Right Looks Like

The strongest companies run both tracks simultaneously. Consumer PR builds market visibility and trust. Capital PR builds credibility with investors and financial stakeholders. The messaging isn’t identical, but it is connected. 

Both audiences should encounter the same underlying market thesis, values, and strategic direction adopted for the decisions they are making. Building that shared foundation before execution begins is exactly what the Avaans Media Fingerprint Strategy is designed to do. That shared foundation is also what gives reputation measurable value as an asset, not just a perception.

Case Study: A consumer wellness brand in a regulated category started building both tracks three years before its IPO window. The consumer track built market credibility. The capital track built the independent editorial record investors would find during due diligence. By the time the raise began, neither audience was starting from scratch. The IPO was oversubscribed. The stock increased 300% at close. See the full case study

Companies that handle this well tend to start earlier than feels necessary because the audience they need to persuade takes longer to move than consumers do. 

Capital PR depends on credibility that accumulates over time. Valuation is rarely determined by a single quarter, a single pitch deck, or a single news cycle; it’s shaped by the narrative record a company builds over years. 

The companies that perform best during capital events are usually the ones that started building that record years before the raise began.

 If you’re not sure where your narrative stands with either audience right now, an assessment is the right starting point.

 Ready to go deeper on how the two tracks work together in practice? See how consumer PR and investor PR reinforce each other and why most agencies only do one.


The Invisible Asset, written by Avaans Media founder Tara Coomans, is the PR ROI framework that builds brand equity, drives valuation, attracts capital, and wins high-stakes moments. It’s built for CMOs defending budgets, CEOs preparing for a capital event, and operators in regulated categories. Get the book →

Most regulated consumer brands aren’t running one communications strategy. They’re running two, and most of the time, those two strategies have never actually met.

The consumer team is focused on product launches, retail placements, and lifestyle media. The investor or financial communications function, whether that’s inside or outsourced, is focused on business press, capital credibility, and executive positioning. Both are doing their job, but neither is thinking about what the other is saying.

That separation feels like operational efficiency. In practice, it’s one of the most common reasons regulated consumer brands underperform on brand authority, the kind that compounds over time and shows up in both market demand and valuation. That compounding effect is what makes narrative strategy a valuation lever, not just a communications exercise.

When these two functions operate from the same strategic foundation, every piece of work does more. A well-placed story in trade press serves the consumer audience and lands in investor due diligence. Executive visibility built for credibility with capital audiences also signals category authority to buyers. The same underlying narrative, translated appropriately for each audience, creates reinforcing proof across both rooms.

That’s brand authority strategy. Not two tracks running in parallel. One narrative, well-architected, executed across two communications streams that make each other stronger.

If you’re a regulated consumer brand managing both a consumer audience and a capital audience right now, an assessment will show you where the two streams align and where the gaps are creating risk

The Structural Reason These Functions Drift Apart

Consumer PR and Investor PR evolved separately because they serve different audiences with different priorities.

Consumer communications are built around product stories, editorial calendars, lifestyle and trade media relationships, and the metrics that matter to marketing: awareness, share of voice, purchase consideration, sentiment. The work is outward-facing and audience-building.

Investor and financial communications are built around business performance, growth narrative, market opportunity, and leadership credibility. The audiences are smaller, the scrutiny is higher, and for regulated brands, the disclosure rules are real. Material information can’t appear in a founder’s Instagram story. PE-backed brands face this same discipline continuously through the hold period, not just at a single fundraising or exit moment. A product narrative that overpromises in a capital context creates regulatory risk that no amount of positive coverage can fix. 

These structural differences mean that agencies on each side have different skills, different editorial relationships, and different definitions of a good outcome. Most consumer PR firms have never placed a story in Bloomberg. Most financial communications firms don’t have relationships with the editors who cover CPG or health and wellness. Both are good at what they do. Neither was designed to do the other’s job.

The problem starts when no one in the organization owns the space between them.

What Happens When the Two Tracks Align

Brand authority is built when multiple audiences encounter evidence that supports the same underlying story. The goal isn’t for every audience to consume the same content. In fact, they usually don’t.

A consumer reads about your product in Allure. An investor reads executive commentary in business media. An analyst encounters your perspective at a conference. Each audience sees a different angle. Authority emerges when those angles point toward the same conclusion.

A consumer should come away believing the brand is credible and relevant. An investor should come away believing the company understands its market and has a defensible position within it. A strategic buyer should encounter evidence of both.

Case Study: A publicly traded global consumer brand entering the U.S. market needed to reach consumers, industry stakeholders, and financial audiences without creating narrative drift. Avaans Media built a unified messaging architecture that supported consumer, executive, and industry communications simultaneously. Eight months later, the company held 93% share of voice and had become the leading online destination in its category. See the full case study.

What Integration Looks Like 

An integrated communications strategy for a regulated consumer brand isn’t about using the same press release for two audiences. It’s about a single messaging architecture that can serve both, with appropriate translation depending on the room.

In practice, that starts with a unified positioning statement that holds under pressure. The core narrative, what the company is, why it matters, what problem it solves, has to be consistent whether a journalist is writing for Allure or for the Financial Times. The emphasis shifts, but the facts don’t change, and the story doesn’t contradict itself.

It means executive visibility built to work in both directions. A CEO who appears in credible trade press as a category expert is more compelling to investors than one who only appears in investor announcements. The trade coverage functions as third-party validation. It’s proof that the brand has earned authority in its own market, from sources that have no stake in the financing outcome.

It also means timeline coordination. Consumer PR has its own cadence: product launches, seasonal campaigns, retail windows. Capital communications has its own cadence: fundraising milestones, strategic announcements, exit preparation. When those timelines are managed together, they amplify each other. A strong run of consumer coverage before a Series B close isn’t an accident, it’s a planned part of the narrative strategy.

And it means a coordinated response plan for when something goes wrong. Regulated brands face specific regulatory exposure. A response designed to protect consumer trust can inadvertently create investor relations problems if the two functions aren’t coordinated. The reverse is just as true. Managing investor perception by going quiet during a consumer-facing crisis often compounds the damage on both sides.

Case Study: A privately owned consumer electronics company needed PR that could move product with consumers and build investor-grade credibility at the same time. One narrative served both. In eight months: 1 billion+ earned media impressions, a Today Show segment that drove the brand’s highest single-day sales since founding, a 25% share of voice gain against major household competitors, and international growth capital secured. See the full case study.

What Happens When They Don’t Align

Narrative Leakage happens when a company’s communications don’t tell a consistent story.  Communications activity accumulates, but a clear authority position does not. 

In regulated industries, this gets more complicated. A cannabis brand heading toward an acquisition may have spent years building a sophisticated consumer brand. But if the investor narrative doesn’t match, if the category framing, the growth thesis, and the risk management story don’t align with what the consumer press has been saying, sophisticated counterparties notice. They don’t ask about it directly, they just underwrite more conservatively.

A healthtech company preparing for an IPO faces the same tension. The consumer narrative may emphasize accessibility and patient experience. The investor narrative may emphasize reimbursement positioning, regulatory clearances, and retention metrics. Both are true. But if no one is managing the relationship between those two stories, the company presents differently in different rooms, and that inconsistency becomes a narrative risk that’s harder to price away than a bad quarter. That risk is exactly what shows up when narrative strategy isn’t treated as its own discipline in regulated categories.

Why Most Agencies Only Do One

Consumer PR agencies are built for product and lifestyle media. Their relationships are with editors who cover CPG, health, beauty, food, and retail. Their pitch rhythms are seasonal, and their metrics are awareness-based. They’re good at what they do, and what they do is genuinely different from financial communications.

Investor and financial PR practitioners think in terms of shareholder messaging, earnings narratives, regulatory windows, and the investor relations function. Their relationships are with the business and financial press. The skill set doesn’t transfer easily in either direction, and most practitioners in both areas will tell you that honestly.

Agencies specialize because the two disciplines require different expertise. The problem is that regulated consumer brands in capital-intensive growth stages often lack an internal function that owns the connection between them. They hire two agencies that never talk to each other, or hire one and assume the other will sort itself out. Without someone at the CEO or CMO level owning that integration point, neither approach works.

Case Study: A venture-funded CPG brand needed visibility with consumers, retail buyers, and investors at the same time. Avaans Media integrated lifestyle media, retail trade coverage, and executive thought leadership into a single communications strategy, helping the company expand into 10 new states and an international market. See the full case study

The Question To Ask an Agency

If you’re evaluating PR agencies as a regulated consumer brand with capital ambitions, one question cuts through the deck faster than anything else.

Ask them: Can you show me an example where your work served both a consumer audience and an investor or business press audience from the same campaign, and walk me through how the strategy was designed to do both?

Not two separate case studies. One example where both were intentional

Most agencies will pivot to a case study of one or the other. Some will talk about coordination with a partner agency, which is worth understanding in more detail if the coordination is real and structured. But if the answer is a blank stare, or a reassurance that the two functions don’t need to talk to each other, you know what you’re buying.

Building Authority Before You Need It

The Fingerprint PR Strategy starts with the questions: What does each of your audiences need to hear? Where does your current narrative serve both? Where is leakage already happening?

If your consumer and investor communications are operating on separate tracks that have never been formally connected, that’s a solvable problem. But it’s better solved before a raise, an exit conversation, or a regulatory moment, not during one.

If you’d like to evaluate where your current brand authority strategy stands and what it would take to build something that compounds across both audiences, that’s exactly what an assessment surfaces.

 

The Invisible Asset, written by Avaans Media founder Tara Coomans, is the PR ROI framework that builds brand equity, drives valuation, attracts capital, and wins high-stakes moments. It’s built for CMOs defending budgets, CEOs preparing for a capital event, and operators in regulated categories. Get the book →

Most brands think of PR as a single channel, with one voice, one strategy, and one team managing the message. That works well when your only audience is consumers.

But regulated consumer brand strategy rarely serves just one audience. If you’re operating in healthcare, pharma, cannabis, alcohol, fintech, energy, or another regulated sector, and you’re raising capital, preparing for an IPO, pursuing an acquisition, or already publicly traded, your communications strategy serves two very different groups: customers and investors.

Consumers are deciding whether to buy. Investors are deciding what the company may be worth. Early on, PR primarily influences awareness, trust, and demand. Once capital enters the picture, communications begin influencing credibility, investor confidence, and ultimately valuation. 

For regulated brands, where disclosure obligations and compliance requirements add another layer of complexity, treating those audiences as a single communication stream can create real risk.

The solution isn’t two different stories, it’s two coordinated communications tracks built from the same strategic foundation.

If you’re a regulated consumer brand navigating both audiences right now, an assessment  will tell you which stream is working and where the gaps are.

Why Regulated Consumer Brand Strategy Requires Two Tracks

Consumer PR is built to drive awareness, trust, and preference. Investor communications are built to communicate business performance, growth strategy, market opportunity, risk management, and leadership credibility. These are not stylistic differences: these are structural ones.

Consumer communications influence purchasing decisions. Investor communications influence confidence in the business. One affects revenue, and the other affects access to capital, strategic opportunities, and valuation.

For regulated brands, the distinction becomes even more important because financial communications are governed by disclosure requirements that don’t apply to most consumer marketing efforts. Material information can’t simply appear in a founder’s social media post, a brand campaign, or a company blog.

Selective disclosure can create regulatory scrutiny, legal exposure, and investor relations problems that no amount of positive coverage can fix.

When a Second Communications Track Becomes Necessary

Many private companies assume these concerns begin at IPO, but in reality, the need for a second communications track often starts years earlier.

The first trigger is fundraising. Once institutional investors begin evaluating the company, public-facing communications become part of the diligence process.

The second trigger is IPO preparation. Quiet period restrictions and gun jumping concerns mean that seemingly routine public statements can create complications if they’re not coordinated with financial communications.

The third trigger is strategic transactions: M&A conversations, secondary transactions, and late-stage rounds increasingly involve sophisticated financial counterparties who are reading your public narrative alongside your financial materials. That’s especially true for PE-backed brands managing this coordination through an entire hold period, not just at the moment of a deal.

Why Regulated Consumer Brands Face Even Higher Stakes

Regulated industries carry an additional layer of complexity because the product itself is subject to oversight, and that oversight doesn’t stop caring about how you communicate just because a message was intended for consumers.

Consider a healthtech company preparing for an IPO. Its consumer narrative may focus on accessibility, patient outcomes, and the experience of care. Its investor narrative may focus on reimbursement positioning, revenue growth, regulatory clearances, retention metrics, and market expansion. The underlying story is the same, the company is the same, the strategic thesis is the same, but what changes is how that story is translated for each audience and the rules governing how it can be communicated.

Regulated brands can absolutely have vibrant, compelling consumer communications, and they should. The requirement is that someone be thinking about both sets of rules simultaneously, with those conversations happening before content goes out, not after.

Consumer PR and Investor PR Serve Different Jobs

Consumer PR leads with product, brand, and story. Success is measured through awareness, reputation, engagement, and customer acquisition.

Investor communications lead with business performance, strategy, and market opportunity. Success is measured through credibility, confidence, and valuation support. 

The two tracks rely on different proof points, approval processes, timelines, and often different spokespeople. Yet both should reinforce the same underlying narrative about where the company is headed and why it matters.

Where Consumer PR and Investor PR Break Down

Most brands struggle with this because the two functions are not aligned. These are coordination failures:

  1. A product launch uses aggressive language about category disruption while the company is preparing for a financing event.
  2. A founder comments publicly on a regulatory development without consulting legal or investor relations.
  3. The consumer communications team is unaware of upcoming financial disclosures.

Over time, these disconnects create gaps between the consumer narrative and the investor narrative. Avaans Media calls this narrative leakage, and for regulated brands engaged in capital conversations, it’s one of the most common and costly communications challenges. The discipline required to prevent it is its own strategic problem, worth solving before the two tracks ever launch.

The Avaans Media Fingerprint Strategy is designed to identify what each audience needs to hear, where narrative leverage exists, and which elements belong in each communications track while keeping the underlying story aligned.

Case Study:  A publicly traded global brand entering the U.S. market needed to reach consumers, industry stakeholders, and investors without creating regulatory or reputational risk. Avaans Media built coordinated consumer, executive, and industry communications that helped the company achieve 93% share of voice and become the leading online destination in its category.

The Bottom Line

Regulated consumer brands that are raising capital, preparing for an exit, or operating in public markets are communicating with two audiences that operate under very different rules. The strongest regulated consumer brand strategy builds one strategic narrative and execute it through two coordinated communications tracks. 

Done well, consumer communications build trust in the product, while investor communication builds confidence in the business. Together, they create the kind of authority that supports both market demand and long-term valuation.

If your two communications tracks aren’t coordinated yet, reach out to Avaans Media for an assessment. It maps where each one stands today and what it takes to run them in sync.



The Invisible Asset, written by Avaans Media founder Tara Coomans, is the PR ROI framework that builds brand equity, drives valuation, attracts capital, and wins high-stakes moments. It’s built for CMOs defending budgets, CEOs preparing for a capital event, and operators in regulated categories. Get the book →

By the time you start preparing for a raise, investors have usually already started forming a view.

At some point, usually well before the process formally begins, you’ve been asked to “get PR in place.” Build visibility, shape the narrative, and make sure the company shows up the right way when investors start looking. In healthtech that usually means some version of investor-facing communications, even if it isn’t described that way.

What’s rarely defined is what that actually needs to do. Because by the time anyone is looking closely, they’ve already formed an initial view. Not from the deck, or from a single conversation, but from what’s been published about the company, how the leadership talks about the product, and whether those two things line up.

PR works in the space between how a company describes itself and how outside observers read it. By the time a healthtech company is formally raising, that external view is already taking shape. Investors have looked at what’s publicly available, noticed patterns, and made early judgments about credibility.

Most teams aren’t measuring against that process. They’re measuring what’s easiest to collect and report: coverage, impressions, and volume, because it’s familiar and creates the appearance of momentum. It also avoids a harder question about what PR is supposed to change.

In a healthtech raise, the question is not how much visibility the company has generated. It’s whether the company feels credible, disciplined, and coherent when someone starts evaluating it from the outside. If your measurement framework isn’t tracking that, it won’t tell you anything useful when someone asks.

An Assessment tells you what your PR is actually doing for your raise, and what it isn’t.

Measurement breaks when it stays at the activity level

Healthtech introduces a different set of constraints than most B2B sectors. Timelines are longer, diligence is deeper, and there are more ways for risk to enter the story, not all of them tied to the product itself. Some of the risk comes from how the company is described and how consistently that description holds up.

The regulatory layer makes this more concrete. Guidance from the U.S. Food and Drug Administration continues to evolve, particularly around software and AI-driven interventions. At the same time, the Federal Trade Commission has increased scrutiny on how health-related claims are communicated. That affects more than legal review, it shapes how language is picked up, repeated, and interpreted across different contexts. That is often where issues begin in regulated industries. A statement that is accurate in one setting can read as overstated in another once it loses its qualifiers. Over time, those small shifts accumulate. Most reporting frameworks don’t capture that, because they track volume, not effect.

The narrative is rarely coming from one place

Inside the company, the story is being constructed from multiple perspectives.

  • Clinical teams are grounded in data and interpretation
  • Regulatory and legal are focused on constraints and defensibility
  • Product is oriented toward what is coming next
  • Finance is evaluating risk, timing, and return

Each perspective is valid, but they aren’t naturally aligned. That misalignment isn’t unusual, but it becomes more pronounced in emerging categories like healthtech.

PR typically sits on top of those inputs, often without the authority to resolve the differences before external communication begins. The result is a narrative that is directionally consistent but not fully coherent when encountered more than once. This doesn’t usually create an obvious issue in a single piece of coverage. It becomes visible when someone reads across multiple sources and begins to notice that the emphasis shifts depending on the context. That kind of inconsistency is enough to slow a diligence process. This is the same discipline problem that shows up across regulated industries generally, not just healthtech.

What the measurement question actually is

Once the problem is framed correctly, the measurement question becomes more precise. The question isn’t whether PR is working in a general sense, but whether the company is becoming easier or harder to evaluate.

In healthtech, investors tend to focus on three things:

1. Whether the clinical evidence holds up
2. Whether the company has been careful about regulatory claims
3. Whether the story stays consistent when it moves from a pitch into technical or regulatory detail

They show up in where the company appears, how it is described, and whether that description holds across different conversations, and in how those signals are built deliberately over time. Coverage can build those signals or undermine them. Aggregate metrics won’t tell you which one is happening.

Translating PR into something a board recognizes

PR measurement still needs to connect to financial language. Share of voice relative to market position, brand-driven acquisition efficiency, and approaches like the royalty relief method all exist for a reason. They give boards and CFOs a way to connect PR to business outcomes rather than just activity.The same demand for financial translation shows up in PE-backed boards during the hold period, not just VC-backed ones preparing to raise.

But in healthtech, the structure isn’t the hard part. The input is, especially as investors become more selective about what they’re willing to underwrite, a shift reflected in recent healthtech investment trends.

Alignment is the work that gets skipped

Most measurement problems can be traced back to a lack of alignment early in the process. Before PR activity begins, there needs to be agreement across clinical, regulatory, product, finance, and communications on what the company must demonstrate by the time it raises capital.

That means agreeing on what the company needs to have demonstrated, in published research,  regulatory filings, and how the product is described before the raise begins. Without it, you’re measuring output, not progress. That alignment is also what makes narrative strategy function as a valuation lever at exit, not just at fundraise.

Adjusting midstream

If PR is already underway without that alignment, the correction point is the investor perspective. Investors typically get stuck on the same few questions:

1. Does the product actually do what the company says it does?
2. Can a health system realistically adopt it?
3. Is there a reimbursement path that doesn’t require an act of Congress?
4. Whether the company communicates discipline.

This last point is where PR either holds up or it doesn’t,  and where you can see the difference most clearly in real growth scenarios.

PR doesn’t influence a raise through isolated moments; it builds through accumulation. The company is being cited in clinical publications, quoted in trade press that investors actually read, and showing up in the same conversations as the category leaders.

Avaans Media success story: A consumer wellness brand in a regulated, emerging category started building both tracks three years before its IPO window. No burst of pre-raise activity, just consistent, deliberate positioning in clinical, trade, and business press, with each layer making the next one easier to earn. By the time institutional investors started due diligence, the public record was already there: 200+ placements, 10 billion earned media impressions, a coherent executive narrative across the right channels. The IPO was oversubscribed. The stock increased 300% at close. See the full case study.

Building the Foundation Before the Raise

The measurement problem most healthtech companies face isn’t a reporting problem, it’s a foundation problem. The narrative was never built to serve both audiences simultaneously, and by the time the raise begins, the gap is already showing up in due diligence.

Avaans Media works with healthtech companies to build that foundation before it’s needed. Every engagement starts with the Fingerprint Strategy, a strategic diagnostic that maps where the brand actually stands, what each audience needs to hear, and where the narrative leverage is before a single pitch goes out. The output isn’t a press calendar. It’s a clear picture of what brand authority needs to be built, for whom, and in what order, so the public record investors find during due diligence is already working for you.

Brand authority is what both tracks are building toward. Customers pay more for it, investors assign a premium to it, and acquirers move through due diligence faster when it’s established. The companies that strategically build it are the ones that show up to those conversations from a position of strength.

If your PR program isn’t building toward that, an Assessment is the right starting point.

Questions CMOs Ask

How should a healthtech CMO measure PR effectiveness for investors?

The most defensible frameworks connect PR to how investors evaluate risk, not how teams report activity.

Share of voice relative to market position is still useful, but only if that visibility is happening in credible environments. Brand-driven CAC efficiency can translate PR into financial terms, but it assumes the underlying narrative is trusted enough to convert.

For companies ahead of meaningful revenue, approaches like the royalty relief method can isolate brand value as an asset. In healthtech, that value is heavily influenced by clinical credibility, regulatory discipline, and whether the story holds up under scrutiny.

The framework matters less than the question it’s built to answer. If it doesn’t map to what an investor needs to believe before underwriting the risk, it won’t hold up in a board conversation.

What’s different about PR for healthtech companies compared to other B2B sectors?

Three dynamics tend to shape how PR functions in healthtech.

First, the audience mix carries different consequences. Investors are evaluating risk and scalability. Clinicians are evaluating evidence. Regulators are evaluating claims. Those groups don’t respond to the same signals, and moving one in the wrong direction can create exposure, not just noise.

Second, regulatory and claims risk is built into how the story is told. A statement that is accurate in one context can become problematic once it’s repeated elsewhere without the same qualifiers. PR is not just shaping perception; it’s shaping how the company is interpreted.

Third, the timeline from validation to scale means that credibility often precedes revenue. What exists early is a pattern of signals, where the company shows up, who engages with it, and how consistently the narrative holds. That pattern becomes a proxy for quality long before financial metrics are fully developed.

When should a healthtech company start building its PR measurement framework?

Before the program starts, not after.

In practice, that means before an agency is engaged, before coverage goals are set, and ideally before PR is even framed as a line item.

The measurement framework should come out of the same conversation that defines what the company needs to demonstrate in order to raise capital. Not messaging, but proof. What has to be believed, and what would make that belief reasonable.

Most teams avoid that conversation because it requires alignment across clinical, regulatory, product, finance, and communications. It’s easier to start generating activity and define success later.

That works until the moment someone asks what PR is actually doing for the raise.

What signals actually matter to investors evaluating a healthtech company?

Investors are rarely reacting to a single piece of coverage. They’re responding to the accumulation of signals.

Where the company appears, and whether those environments carry weight. How consistently the company is described across different contexts. Whether the narrative holds when you move from marketing language to technical or regulatory detail.

Individually, none of these are decisive. Together, they shape whether the company feels credible, disciplined, and investable.

Those signals are measurable, but not through volume alone. They require a framework that looks at pattern, consistency, and context over time.

Request a PR Evaluation Assessment

Sources

 

The Invisible Asset, written by Avaans Media founder Tara Coomans, is the PR ROI framework that builds brand equity, drives valuation, attracts capital, and wins high-stakes moments. It’s built for CMOs defending budgets, CEOs preparing for a capital event, and operators in regulated categories. Get the book →

Blogarama - Blog Directory